Monografie

Versorgungsrealität der stationären vasoaktiven Therapie mit Prostazyklinderivaten bei Patienten mit akralen Durchblutungsstörungen bei systemischer Sklerose in Deutschland = Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany

zu Verbundenen Objekten

Sprache
Deutsch
Identifier
1224808355

Thema
Prostacyclin; Therapeut; Patient; Iloprost; Raynaud-Krankheit; Deutschland

Beteiligte Personen und Organisationen

DOI
10.1007/s00393-019-00743-9
URN
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
26.01.2023, 13:56 MEZ

Datenpartner

Deutsche Nationalbibliothek
Original beim Datenpartner anzeigen

Objekttyp

  • Monografie

Beteiligte

Ähnliche Objekte (12)

Older age onset of systemic sclerosis - accelerated disease progression in all disease subsets

Monografie

Older age onset of systemic sclerosis - accelerated disease progression in all disease subsets

Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis

Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis

Autologous hematopoietic stem cell transplantation improves long-term survival - data from a national registry

Monografie

Autologous hematopoietic stem cell transplantation improves long-term survival - data from a national registry

S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 2: Therapy, risk factors and other special topics

S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 2: Therapy, risk factors and other special topics

S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 2: Therapy, risk factors and other special topics

S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 2: Therapy, risk factors and other special topics

S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 1: Classification, diagnosis, prevention, activity scores

S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 1: Classification, diagnosis, prevention, activity scores

S2k guideline: Diagnosis and management of cutaneous lupus erythematosus - Part 1: Classification, diagnosis, prevention, activity scores

S2k guideline: Diagnosis and management of cutaneous lupus erythematosus - Part 1: Classification, diagnosis, prevention, activity scores

Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database

Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database

Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study

Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study

Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis

Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis

Gastrointestinale Beteiligung bei Systemischer Sklerose

Monografie

Gastrointestinale Beteiligung bei Systemischer Sklerose

An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod

An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod

Verbundene Objekte